Acute Myeloid Leukemia

CLINICAL_TRIALS trial_result · 2013-07-04

Clinical Trial Update: Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia [Phase 2]

Phase 2 trial evaluating lenalidomide in older adults with acute myeloid leukemia has been completed with results posted in 2013.

CLINICAL_TRIALS trial_result · 2013-07-03

Clinical Trial Update: Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome [Phase 2]

This entry updates a Phase 2 chemotherapy trial for newly diagnosed acute myeloid leukemia, chronic myeloid leukemia, and myelodysplastic sy…

CLINICAL_TRIALS trial_result · 2013-07-02

Clinical Trial Update: Decitabine, Cytarabine, GCSF for Refractory AML/MDS [Phase 2]

Phase 2 trial of decitabine, cytarabine, and GCSF for refractory AML/MDS was terminated with results posted.

CLINICAL_TRIALS trial_result · 2013-07-02

Clinical Trial Update: A Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies [Phase 1]

A Phase 1 dose-escalation study of TAK-901 in subjects with advanced hematologic malignancies; the trial has completed.

CLINICAL_TRIALS trial_result · 2013-06-28

Clinical Trial Update: Interleukin-2 in Treating Children Who Have Undergone Bone Marrow Transplantation for Acute Myeloid Leukemia [Phase 1]

A Phase 1 clinical trial evaluating interleukin-2 in children who have undergone bone marrow transplantation for acute myeloid leukemia has …

CLINICAL_TRIALS trial_result · 2013-06-27

Clinical Trial Update: Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome [Phase 3]

A Phase 3 clinical trial evaluating chemotherapy in children with Down syndrome and myelodysplastic/myeloproliferative disorders, acute myel…

CLINICAL_TRIALS trial_result · 2013-06-26

Clinical Trial Update: Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia [Phase 1, Phase 2]

A Phase 1/2 clinical trial comparing combination chemotherapy followed by peripheral stem cell transplantation versus isotretinoin in patien…

CLINICAL_TRIALS trial_result · 2013-06-26

Clinical Trial Update: Haploidentical Natural Killer Cells to Treat Refractory or Relapsed Acute Myelogenous Leukemia (AML) [Phase 2]

Phase 2 trial evaluating haploidentical natural killer cells for refractory or relapsed acute myeloid leukemia has terminated with posted re…

CLINICAL_TRIALS trial_result · 2013-06-25

Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Myelodysplastic Syndrome or Relapsed or Refractory Acute Myeloid Leukemia or Chronic Myelogenous Leukemia [Phase 1]

A Phase 1 clinical trial of a monoclonal antibody therapy was conducted in patients with myelodysplastic syndromes, relapsed or refractory a…

CLINICAL_TRIALS trial_result · 2013-06-24

Clinical Trial Update: High-dose Cytarabine/Mitoxantrone Followed by Autotransplantation for t-MDS/t-AML [Phase 2]

A Phase 2 clinical trial evaluating high-dose cytarabine and mitoxantrone followed by autologous transplantation for therapy-related myelody…

CLINICAL_TRIALS trial_result · 2013-06-24

Clinical Trial Update: Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer [Phase 2]

Phase 2 clinical trial update examining the combination of phenylbutyrate and azacitidine in patients with acute myeloid leukemia, myelodysp…

CLINICAL_TRIALS trial_result · 2013-06-24

Clinical Trial Update: flt3L in Treating Patients With Acute Myeloid Leukemia [Phase 3]

Phase 3 trial evaluating FLT3 ligand (flt3L) in treating acute myeloid leukemia has completed.

CLINICAL_TRIALS trial_result · 2013-06-20

Clinical Trial Update: Standard vs. Reduced-Intensity Conditioning in Patients With Acute Myeloid Leukemia in First Remission [Phase 3]

A Phase 3 trial comparing standard versus reduced-intensity conditioning in patients with Acute Myeloid Leukemia in first remission was term…

CLINICAL_TRIALS trial_result · 2013-06-19

Clinical Trial Update: Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia [Phase 2]

A Phase 2 trial comparing Leridistim with Filgrastim in older adults with acute myeloid leukemia to assess safety and effectiveness in treat…

CLINICAL_TRIALS trial_result · 2013-06-19

Clinical Trial Update: Mylotarg and Ara-C in Untreated Patients Above 60 Years With AML and High-Risk MDS [Phase 2]

Phase 2 trial evaluating Mylotarg in combination with cytarabine in untreated patients over 60 with acute myeloid leukemia and high-risk mye…

CLINICAL_TRIALS trial_result · 2013-06-11

Clinical Trial Update: Busulfan Pharmacokinetic Analysis and GST Pharmacogenetic Profile in Adults Undergoing Hematological Stem Cell Transplantation

A completed clinical trial analyzing busulfan pharmacokinetics and GST pharmacogenetics in adults undergoing hematologic stem cell transplan…

CLINICAL_TRIALS trial_result · 2013-06-05

Clinical Trial Update: Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia [Phase 3]

This Phase 3 clinical trial compares tretinoin, cytarabine, and daunorubicin with or without arsenic trioxide, followed by tretinoin with or…

CLINICAL_TRIALS trial_result · 2013-06-05

Clinical Trial Update: 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia [Phase 1]

Phase 1 clinical trial evaluating safety and dosing of 17-N-allylamino-17-demethoxygeldanamycin (tanespimycin) in pediatric patients with re…